An interventional study of Nutritional intervention in Bipolar Depression and Bipolar Disorder (BD), sponsored by University of Sao Paulo. Recruiting at 1 site in Brazil. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-03-02.
Sponsored by University of Sao Paulo · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Bipolar Disorder by University of Sao Paulo — 3 open to participants now, 4 under way, 1 of them phase 3. Bipolar Disorder · University of Sao Paulo.
Among the 15 studies in Bipolar Disorder by University of Sao Paulo, this one is the 4th largest by planned enrollment of the 13 interventional ones that give a count, is one of 3 that started in 2026, is one of 7 with no phase, and was the 13th registered.
1,687 studies on the registry are indexed under Bipolar Disorder; 268 are open to participants now.
Browse Bipolar Disorder studies →3 of the 15 studies in Bipolar Disorder by University of Sao Paulo are open now, in 1 country. Recruiting first, the newest first:
University of Sao Paulo · Sites in Brazil
Ages 18–65
University of Sao Paulo · Sites in Brazil
Ages 18–65
By country, each count listing its studies:
Of the 207 Bipolar Disorder studies recruiting now, 60 (29%) set no upper age limit and 134 (65%) stop at 75 or younger; 38 take children under 18; 51 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 4 · Phase 3 3 · Phase 4 1
First in 2010; this study’s year is marked. 3 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 88 is above the median of 64 across 1,282 interventional studies indexed under Bipolar Disorder.
Median enrollment 60 across the 13 interventional studies, 130 across the 2 observational. Of the 5 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Sao Paulo is the lead sponsor of 1,036 studies on the registry; 96 are open to participants now.
Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Bipolar Disorder by University of Sao Paulo that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07412132Phase 3University of Sao PauloEvaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II. | 2027-01 |
| NCT06488573University of Sao PauloPROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder | 2026-11 |
| NCT07472920University of Sao PauloEmpagliflozin Adjunctive Therapy in Bipolar Depression | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 15 studies in Bipolar Disorder by University of Sao Paulo, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Individuals with Bipolar Disorder (BD) have twice the risk of being affected by metabolic comorbidities and a 1.8-fold increased risk of mortality from cardiovascular diseases when compared to the general population. These factors are fundamental in the 14-year reduction in the life expectancy of people with TB reported in recent meta-analyses. This occurs mainly due to the increased inflammation associated with the disease, the adverse effects of pharmacological treatments and unhealthy lifestyle habits that are more common in people diagnosed with BD. Nutrition has been studied as an adjunctive treatment in other psychiatric disorders, but there is a lack of studies about the role of nutrition in TB. Considering that diet can impact metabolic health, this randomized controlled study aims to evaluate the effect of a nutritional intervention on cardiovascular risk in patients with TB. The intervention is based on the dietary pattern recommended in the Dietary Guidelines for the Brazilian Population and will be applied by a registered dietitian. According to the literature, the sample size will be 72 individuals with TB (36 in the control group with usual treatment + 36 in the intervention group added to the usual treatment). The intervention will be carried out in 7 individual sessions and 8 group sessions with specific themes. The primary aim of this protocol will be an intervention to contribute to cardiovascular health - verified by serum markers, anthropometric measurements and the Framingham Cardiovascular Risk Score (algorithm used to estimate an individual's 10-year cardiovascular risk). The secondary stages will be the adherence of the intervention and the impact on the quality of life of the participants. The possible positive results of this nutritional intervention can open new clinical perspectives. Meaning that might show that better food choices can protect the cardiovascular health of individuals with TB, leading to a reduction in morbidity and mortality associated with the disease.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Treatment as usual
Nutritional intervention based on the Brazilian Dietary Guidelines
Behavioral: Nutritional intervention
7 individual sessions (online) + 6 small group sessions (1-in person + 5 online)
C reactive protein
C reactive protein
Time frame: Baseline, week 12, week 24 and follow up at week 52
Total cholesterol and fractions
Total cholesterol and fractions
Time frame: Baseline, week 12, week 24 and follow up at week 52
Glycemia
Glycemia
Time frame: Baseline, week 12, week 24 and follow up at week 52
Glycated hemoglobin A1C
Glycated hemoglobin A1C
Time frame: Baseline, week 12, week 24 and follow up at week 52
Triglycerides
Triglycerides
Time frame: Baseline, week 12, week 24 and follow up at week 52
HOMA IR
HOME IR
Time frame: Baseline, week 12, week 24 and follow up at week 52
Apoliporpotein B
Apoliporpotein B
Time frame: Baseline, week 12, week 24 and follow up at week 52
Cardiovascular risk
Framingham Global Risk Score (-3 to 21; higher scores mean worse outcome)
Time frame: Baseline, week 12, week 24 and follow up at week 52
Body weight
Body weight
Time frame: Baseline, week 12, week 24 and follow up at week 52
Body fat percentage
Body fat percentage
Time frame: Baseline, week 12, week 24 and follow up at week 52
waist circumference
waist circumference
Time frame: Baseline, week 12, week 24 and follow up at week 52
Dietary assessment - dietary intake
3-day food record from last week (calories and macronutrients)
Time frame: Baseline, week 12, week 24 and follow up at week 52
Dietary assessment - dietary quality
ESQUADA (0-375; higher scores mean better outcome)
Time frame: Baseline, week 12, week 24 and follow up at week 52
Dietary assessment - dietary adehrence
NUTRINET (0-72; higher scores mean worse outcome)
Time frame: Baseline, week 12, week 24 and follow up at week 52
Quality of life WHOQOL
WHOQOL Bref Portuguese (0-100; higher scores mean better outcome)
Time frame: Baseline, week 12, week 24 and follow up at week 52
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Apr 2026; primary completion for Nov 2026, 7 months later.
Of 361 non-industry interventional studies with no phase under Bipolar Disorder, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 58. This study's planned 7 months is below that.
Counting every sponsor, half of 363 studies reached it within 37 months; a quarter within 23 and three quarters within 58.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.